Refresh

Sun Pharma Advanced Research Company Ltd. - Research Center

532872 SPARC Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

75.55 238.78 137.25 252.96 76.81
Expenses

Material consumed

34.44 27.27 22.65 22.65 27.90

Manufacturing expenses

286.38 287.16 183.91 251.99 174.44

Personnel expenses

118.53 107.00 96.78 91.59 93.09

Selling expenses

- - - - -

Adminstrative expenses

39.99 31.41 20.67 21.71 91.41

Expenses capitalised

- - - - -

Cost of sales

479.34 452.84 324.00 387.93 386.83

Operating profit

-403.79 -214.06 -186.75 -134.98 -310.01

Other recurring income

29.47 10.88 6.84 5.41 9.76

Adjusted PBDIT

-374.32 -203.18 -179.90 -129.57 -300.25

Financial expenses

1.66 7.63 13.33 10.65 2.67

Depreciation

12.13 11.77 10.16 10.92 9.48

Other write offs

- - - - -

Adjusted PBT

-388.11 -222.58 -203.40 -151.14 -312.40

Tax charges

- - - - -

Adjusted PAT

- - - - -

Non recurring items

0.19 1.35 1.70 1.53 -2.47

Other non cash adjustments

- - - - -

Reported net profit

-387.92 -221.23 -201.70 -149.61 -314.87

Earnigs before appropriation

-1,979.73 -1,591.81 -1,370.58 -1,168.88 -1,019.27

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-1,979.73 -1,591.81 -1,370.58 -1,168.88 -1,019.27
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com